The public, increasingly, sees Wall Street behavior as an illness, and the new CNBC story about Wall Street traders shooting up with testosterone will only add to that perception. Various life-shortening drugs, legal and otherwise, are an everyday part of the picture in the world of high finance, but testosterone is something different. The rationale for artificially high testosterone levels is that it may prompt a trader to make wilder, more aggressive, less responsible decisions with the large sums of money they are responsible for.
Considering the various financial disasters that Wall Street has been responsible for already, the addition of a not-entirely-legal drug known to lead to crazier and more aggressive decision-making doesn’t sound like it could possibly end well.
